Mazin Al‐Kasspooles

420 total citations
19 papers, 328 citations indexed

About

Mazin Al‐Kasspooles is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Mazin Al‐Kasspooles has authored 19 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Mazin Al‐Kasspooles's work include Esophageal Cancer Research and Treatment (5 papers), Cancer-related gene regulation (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Mazin Al‐Kasspooles is often cited by papers focused on Esophageal Cancer Research and Treatment (5 papers), Cancer-related gene regulation (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Mazin Al‐Kasspooles collaborates with scholars based in United States. Mazin Al‐Kasspooles's co-authors include Jason H. Moore, David G. Beer, Mark B. Orringer, Seong‐Wook Lee, MB Orringer, Peter J. DiPasco, Mark S. Cohen, Joseph Valentino, John Park and Anne Walling and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mazin Al‐Kasspooles

18 papers receiving 318 citations

Peers

Mazin Al‐Kasspooles
Iain Paterson United Kingdom
Ken Kato Japan
C. Peschel Germany
Sanaz Ainechi United States
Michele M. Gage United States
Iain Paterson United Kingdom
Mazin Al‐Kasspooles
Citations per year, relative to Mazin Al‐Kasspooles Mazin Al‐Kasspooles (= 1×) peers Iain Paterson

Countries citing papers authored by Mazin Al‐Kasspooles

Since Specialization
Citations

This map shows the geographic impact of Mazin Al‐Kasspooles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazin Al‐Kasspooles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazin Al‐Kasspooles more than expected).

Fields of papers citing papers by Mazin Al‐Kasspooles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mazin Al‐Kasspooles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazin Al‐Kasspooles. The network helps show where Mazin Al‐Kasspooles may publish in the future.

Co-authorship network of co-authors of Mazin Al‐Kasspooles

This figure shows the co-authorship network connecting the top 25 collaborators of Mazin Al‐Kasspooles. A scholar is included among the top collaborators of Mazin Al‐Kasspooles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazin Al‐Kasspooles. Mazin Al‐Kasspooles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Al‐Kasspooles, Mazin, et al.. (2024). Gastroenteropancreatic Neuroendocrine Tumor with Peritoneal Metastasis: A Review of Current Management. Cancers. 16(20). 3472–3472. 1 indexed citations
2.
Meyer, Mark, et al.. (2023). Adrenocortical Carcinoma as an Atypical Cause of Secondary Hypertension. Kansas Journal of Medicine. 16(1). 114–116.
3.
Sun, Weijing, Anwaar Saeed, Raed Moh’d Taiseer Al-Rajabi, et al.. (2022). A phase II study of perioperative mFOLFOX chemotherapy plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (GEJ), and stomach.. Journal of Clinical Oncology. 40(4_suppl). 329–329. 6 indexed citations
4.
Kasi, Anup, Harri A. Järveläinen, Raed Moh’d Taiseer Al-Rajabi, et al.. (2022). Phase Ib/IIa trial of CEND‐1 in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colorectal, and appendiceal cancers (CENDIFOX).. Journal of Clinical Oncology. 40(16_suppl). TPS4195–TPS4195. 5 indexed citations
5.
Sun, Virginia, Tracy E. Crane, Kathryn B. Arnold, et al.. (2021). SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial). Contemporary Clinical Trials Communications. 22. 100768–100768. 4 indexed citations
6.
Al‐Kasspooles, Mazin, et al.. (2020). Satisfaction or Distraction: Exposure to Nonpreferred Music May Alter the Learning Curve for Surgical Trainees. Journal of surgical education. 77(6). 1370–1376. 4 indexed citations
8.
Baranda, Joaquina, Andrés M. Bur, Terance T. Tsue, et al.. (2019). A window of opportunity trial of atorvastatin targeting p53 mutant malignancies. Annals of Oncology. 30. v795–v795. 1 indexed citations
9.
Baranda, Joaquina, et al.. (2019). Esophageal Cancer: Current and Evolving Treatment Landscape. 4(8). 1 indexed citations
10.
Iwakuma, Tomoo, Andrés M. Bur, Mazin Al‐Kasspooles, et al.. (2019). A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies.. Journal of Clinical Oncology. 37(15_suppl). TPS3165–TPS3165. 3 indexed citations
11.
Walling, Anne, et al.. (2018). Discontinuation of surgical versus nonsurgical clinical trials: an analysis of 88,498 trials. Journal of Surgical Research. 227. 151–157. 13 indexed citations
12.
Valentino, Joseph, et al.. (2018). Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Journal of Gastrointestinal Oncology. 9(5). 828–828. 14 indexed citations
13.
14.
Grauer, Dennis, et al.. (2016). Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors. Thrombosis Research. 147. 104–107. 2 indexed citations
15.
Buckles, Daniel, et al.. (2009). Treatment of Barrett’s esophagus with high-grade dysplasia. Expert Review of Anticancer Therapy. 9(3). 303–316. 1 indexed citations
16.
Park, John, et al.. (2009). A patient with metastatic melanoma of the small bowel.. PubMed. 23(1). 98–102. 10 indexed citations
17.
Mitchell, Melissa P., et al.. (2009). Ser552-Phosphorylated β-Catenin is a Marker of Functional Stem Cells in Patients with Esophageal Cancer before and after Treatment with Neoadjuvant Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 75(3). S534–S534. 1 indexed citations
18.
Al‐Kasspooles, Mazin, et al.. (1995). E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. British Journal of Cancer. 71(1). 166–172. 73 indexed citations
19.
Al‐Kasspooles, Mazin, Jason H. Moore, Mark B. Orringer, & David G. Beer. (1993). Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas. International Journal of Cancer. 54(2). 213–219. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026